G6PD and lung carcinoma: However, G6PD reportedly undergoes modifications such as phosphorylation at Y112 and Y428 [69, 70] in HCT116 cells, acetylation at K403 [71] in leukaemia cells and glycosylation at S84 in lung cancer cells [72].